Ignite Creation Date:
2024-05-06 @ 12:33 AM
Last Modification Date:
2024-10-26 @ 10:51 AM
Study NCT ID:
NCT01607892
Status:
COMPLETED
Last Update Posted:
2023-01-26
First Post:
2012-05-16
Brief Title:
Safety Study of the Selective Inhibitor of Nuclear Export SINE KPT-330 in Patients With Advanced Hematological Cancer
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Karyopharm Therapeutics Inc
Organization Data
Organization:
Karyopharm Therapeutics Inc
Class:
INDUSTRY
Study ID:
KCP-330-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Karyopharm Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None